Skip to content
Search

Latest Stories

Seb James prescribes data sharing between NHS and community pharmacy for better health outcomes

Boots UK supremo Seb James has said better sharing of patient data between community pharmacy and the NHS could transform the way healthcare services are delivered in the country.

Speaking at a Digital Health Rewired event in London on Tuesday (14 March), he spoke of a recent study by Imperial College London which found that customer loyalty card data could be an early predictor of ovarian cancer.


The study tracked the spending of consenting Boots Advantage Card holders to investigate a link between a diagnosis of ovarian cancer and a pattern of buying over-the-counter pain and indigestion medications.

The managing director of Boots UK & ROI said: “Just as we can advise our customers which skincare product might be suitable for them – patient care should be personalised and seamless, offering complete continuity between hospital, GPs and the local pharmacy.

“Not only would this take critical strain out of the NHS system, but it would also crucially make it easier for patients to get access to the care and services they need. One way to help facilitate this is the better sharing of patient data between community pharmacy and the NHS. With patient consent, better data sharing could transform the way healthcare services are delivered.”

Diabetes screening

Boots is also planning to launch a new private pilot diabetes screening tests from May in seven stores across Manchester, London and Birmingham, cities with the most prevalence of diabetes case, with the possibility of spreading it across more stores next year.

James, who believes diabetes could be a particularly suitable area to benefit from greater data sharing between community pharmacy and the NHS, said that Boots could deliver these tests on behalf of the NHS and welcomes conversations with national and local service commissioners.

He said: “There are currently around 850,000 people living with undiagnosed diabetes and we want to help address that. As well as having community pharmacies like Boots perform screening tests, there could be an expanded role for diabetes management in community pharmacy.

"Our pharmacy team members could support with checks when patients collect their medicines and feed this information back to their GP via their patient record. That could be really powerful.”

James also revealed that Boots was extending its partnership with Our Future Health – a project that aims to create one of the most detailed pictures ever of people’s health to help transform the prevention, detection and treatment of diseases.

In a press release, Boots said since last year it has been raising awareness among its Advantage Card members to attract volunteers to take part in the initiative. During a pilot in 10 stores, Boots helped facilitate the recruitment of over 10,000 volunteers since last summer. The partnership which is now being extended to a further 10 stores this month will get another 70 stores to sign up by the end of the year.

Currently, community pharmacies in England do not have full read and write access to NHS patient health records.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less